Testing new blood tests in adults with antiphospholipid antibodies
Treatments studied
Part of Immune system & allergy clinical trials.
This trial studies new laboratory (blood) tests in adults who have antiphospholipid antibodies, a condition that can be linked to blood clots. It may help improve how these antibodies are confirmed and tracked using repeat testing over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You must have confirmed antiphospholipid antibodies, with at least two positive results at least 12 weeks apart.
- You must be willing to take part (able to agree; no non-consent barriers).
- You should not be on blood thinners other than heparin.
- Your platelet count must be 100 billion per liter (100 G/L) or higher.
- You must have good vein access for blood draws.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lab results and clinic information in people who have antiphospholipid antibodies. The goal is to better understand these antibody-positive conditions and what happens over time, which may help improve care.
This trial looks at people who have symptoms of antiphospholipid syndrome (APS) but test negative for the usual antibodies. It will compare these patients to those with positive antibody tests to better understand the condition and improve diagnosis and treatment.
This study is for children who have antiphospholipid syndrome (APS) and a history of blood vessel clots. Researchers want to learn more about APS in pediatric patients who have specific blood test signs and clot history.
This study tests a new quick blood-clotting test (point-of-care INR testing) for patients with antiphospholipid syndrome who take blood thinners. The goal is to see if this faster test works as well as standard lab tests for monitoring their treatment.
This study keeps a registry to follow people with antiphospholipid syndrome (APS) who have had arterial blood clots (like stroke). It collects information about the treatment approach your clinician chooses to see how different antithrombotic regimens may perform and be tolerated.
This study looks at how platelet counts change over time in people with antiphospholipid syndrome (APS), a condition that can cause blood clots and pregnancy problems. It may help doctors better understand and manage low platelets in APS patients.
Hear when a new Antiphospholipid Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.